86.90.E - Healthcare
20.59.Z - Manufacture of other chemical products, not elsewhere classified
21.10.Z - Manufacture of basic pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
47.73.Z - Retail sale of pharmaceutical products
58.11.Z - Publishing of books
71.20.B - Inspection and issuing opinions on the technical condition of chimneys and ventilation ducts
72.11.Z - Scientific research and development activities
72.19.Z - Scientific research and development activities
85.59.B - Courses and training for acquiring knowledge, skills, and professional qualifications in non-school forms
2018 | 2019 | 2020 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | 0,5 | -0,3 | -162,1 | |
Gross profit (loss) | 0,2 | 0,5 | -0,2 | -137,6 |
EBITDA | 0,3 | 0,6 | -0,1 | -115,9 |
Short time liabilities | 0,2 | 0,1 | 0,4 | 265,7 |
Other operating costs | 0 | 0 | -54,8 | |
Equity capital | 0,3 | 0,6 | 0,3 | -46,9 |
Operating profit (EBIT) | 0,2 | 0,5 | -0,2 | -137,6 |
Assets | 0,5 | 0,8 | 0,8 | 1,7 |
Net profit (loss) | 0,2 | 0,4 | -0,2 | -141,5 |
Cash | 0 | 0,2 | 0,2 | 19,3 |
Liabilities and provisions for liabilities | 0,2 | 0,1 | 0,4 | 218,1 |
Net income from sale | 4,2 | 4,6 | 3,6 | -21,7 |
Working assets | 0,4 | 0,6 | 0,7 | 10,5 |
Other income costs | 0 | 0,1 | 5677,4 | |
Depreciation | 0,1 | 0,1 | 0,1 | -31,4 |
% | % | % | p.p. | |
Profitability of capital | 50,5 | 66,2 | -51,7 | -117,9 |
Equity capital to total assets | 65,2 | 81,6 | 42,6 | -39 |
Gross profit margin | 4,8 | 9,7 | -4,7 | -14,4 |
EBITDA Margin | 7,4 | 12,2 | -2,5 | -14,7 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 14 | 9 | 44 | 35 |
Current financial liquidity indicator | 5.315287113189697 | 1.6065233945846558 | -3,7 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane